A drug discovery company dedicated to developing treatments for Neurofibromatosis Type 1

INFIXION TEAM

Core Team

Herb Sarnoff, BS/MBA
Founder & CEO, NF1 Parent
Michelle Mattson-Hoss, PhD
VP, Research & Development
Glenn Croston, PhD
Drug Discovery Consultant
Michael ‘Mick’ Frost, MD
Medical Director, NF1 Parent
Mya Walker, PhD
Scientist
Gwen Guzman
Research Associate II

SCIENTIFIC ADVISORY BOARD

NF1 Thought Leaders

Bob Kesterson, PhD
Louisiana State Univ. (Pennington)
David Viskochil, MD/PhD
University Utah
Bruce Korf, MD/PhD
Univ. Alabama Birmingham
Kaleb Yohay, MD/PhD
New York University

SCIENTIFIC ADVISORY BOARD

Academic / Research Leaders

Gregory Way, PhD
University of Colorado, Anschutz
Machine Learning; Data Science
Evan Snyder, MD/PhD
Sanford Burnham, San Diego
Stem Cells; Regenerative Medicine
James Kadonaga, PhD
UC San Diego
Transcriptional Regulation; Chromatin

Collaborating partners

 

 

 

 

 

 

 

 

 

 

Legal partners

Ⓒ iNFixion Bioscience (2017-2025). All rights reserved.